French Randomized Trial Between ACT and AMS 800 AUS

LATEST NEWS

July 4, 2016

First patients enrolled in French Randomized Trial Between Uromedica’s Adjustable Continence Therapy (ACT) and Boston Scientific’s AMS 800 Artificial Urinary Sphincter (AUS)

Link: